Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stemulite is a multi-ingredient dietary supplement marketed primarily for athletic recovery, sleep enhancement, and the purported recruitment of adult stem cells. Developed by Stemulite LLC, the formulation typically includes a blend of bioactive avian proteins (often referred to as "Stem Cell Recruiter" or avian growth factors), the proteolytic enzyme serratiopeptidase, and antioxidants such as alpha-lipoic acid and quercetin, alongside melatonin to support circadian rhythm and recovery. The product is promoted as a natural means to accelerate tissue repair, reduce inflammation following intense physical exertion, and improve deep sleep cycles. It is categorized as a nutraceutical and is not an FDA-approved pharmaceutical drug for the treatment of specific diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Stemulite.